Across 32 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Patel Snehal, Chairman & CEO. Director active across 1 company, notably Greenwich LifeSciences, Inc.. In total, 81 disclosures have been published. Split: 81 buys · 0 sell. Total volume traded: €5.9m. History available since 14 December 2021. The latest transaction was filed on 29 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Patel Snehal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,000 shares@ US$13.810.5% of flowCommon StockSEC:0001493152-24-030637:0
Canonical exit: 4 Nov 2024 (T+90)
25 of 81 declarations
About Patel Snehal
Patel Snehal is Chief Financial Officer and Chief Executive Officer at Greenwich LifeSciences, Inc. He has 76 filings in total, and in the sampled recent filings, all transactions are acquisitions, with total खरीद? Wait no French/English should be English. Need remove buy typo. Let's craft.